Episurf Medical to present at Redeye Medtech & Diagnostics Seminar on September 28th

Episurf Medical (Nasdaq: EPIS B) will attend Redeye Medtech & Diagnostics Seminar held on September 28th, 2021. The event is arranged by Redeye and the company will be represented by the CEO Pål Ryfors.

The presentation will be streamed live at 13:30 CEST at https://www.redeye.se/events/815786/medtech-diagnostics-2 and will also be made available afterwards on our website www.episurf.com.

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

Tags: